Kaya Holdings (KAYS) Receivables - Other (2014 - 2025)
Kaya Holdings (KAYS) recorded quarterly Receivables - Other of $75000.0 in Q3 2025, down 3.76% quarter-over-quarter from $77929.0 in Q2 2025.
Kaya Holdings (KAYS) Receivables - Other (2014 - 2025) Analysis & Trends
Kaya Holdings' Receivables - Other history runs 3 years deep, the most recent figure standing at $75000.0 for Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | Kaya Holdings | - | - | 5,370.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 75,000.00 |
| Sep 30, 2025 | 75,000.00 |
| Jun 30, 2025 | 77,929.00 |
| Jun 30, 2025 | 77,929.00 |
| Mar 31, 2025 | 461.00 |
| Mar 31, 2025 | 461.00 |
| Sep 30, 2022 | 9,801.00 |
| Sep 30, 2022 | 9,801.00 |
| Jun 30, 2022 | 10,485.00 |
| Jun 30, 2022 | 10,485.00 |
| Mar 31, 2022 | 11,066.00 |
| Mar 31, 2022 | 11,066.00 |
| Jun 30, 2014 | 5,000.00 |
| Jun 30, 2014 | 5,000.00 |
| Mar 31, 2014 | 11,000.00 |
| Mar 31, 2014 | 11,000.00 |